Angiotensin-converting enzyme (ACE) blood test
Pro Research Analysisby 
Searched over 200M research papers
Angiotensin-Converting Enzyme (ACE) Blood Test: Clinical Relevance and Methodology
ACE Blood Test Purpose and Clinical Significance
The angiotensin-converting enzyme (ACE) blood test measures the activity or concentration of ACE in the blood. ACE is a key enzyme involved in blood pressure regulation and vascular remodeling, and its levels can reflect underlying health conditions. Elevated ACE levels in blood are associated with an increased risk of cardiovascular diseases and are also used as a marker for granulomatous diseases such as sarcoidosis 236. The test can also help monitor the effectiveness of ACE inhibitor therapy and screen for genetic or conformational changes in the enzyme 23.
Methodology and Advances in ACE Testing
Traditional Enzyme Activity Assays
ACE activity is commonly measured using synthetic substrates, such as furylacryloyl-phenylalanyl-L-glycyl-L-glycine (FAPGG), in serum or plasma samples. The assay is linear within a specific range (10 to 200 UI/L), and samples can be stored at 4°C for up to a week. The test is highly reliable after proper calibration, with analytical uncertainty between 2% and 5% depending on the ACE value .
ACE Phenotyping for Precision Medicine
Recent advances include ACE phenotyping, which combines activity measurement with two substrates and quantification of ACE protein using monoclonal antibodies. This approach allows for the detection of ACE inhibitors in the blood, identification of individuals with conformationally altered ACE, and establishment of normal ACE values in healthy populations. ACE phenotyping can also help identify patients with genetic mutations affecting ACE and may serve as a sensor for other biomarkers, such as free bilirubin 23.
Novel Biosensor and Mass Spectrometry Approaches
Innovative biosensors, such as plasmonic nanosensors using gold nanoparticles, have been developed for rapid, sensitive, and selective detection of ACE activity. These methods allow for point-of-care testing and screening of ACE inhibitors, which is valuable for both clinical diagnostics and drug development . High-performance liquid chromatography coupled with mass spectrometry (HPLC-ESI-QqQ-MS) is another sensitive method for identifying ACE inhibitors and measuring enzyme activity with high precision .
Genetic Factors Influencing ACE Levels
Genetic variation plays a significant role in determining ACE levels in the blood. The insertion/deletion (I/D) polymorphism of the ACE gene is strongly associated with differences in ACE concentration, accounting for a substantial portion of the variability. Other polymorphisms within the ACE gene also contribute to ACE levels and are linked to blood pressure regulation, with evidence of complex genetic interactions (epistasis) influencing these traits 57.
Clinical Applications and Considerations
The ACE blood test is most commonly used in the diagnosis and monitoring of sarcoidosis, but it also has potential applications in cardiovascular risk assessment and personalized medicine. It is important to consider factors such as age, sex, and genetic background when interpreting ACE levels, as these can influence normal ranges. The test can also be affected by the use of ACE inhibitors, which should be accounted for during analysis 126.
Conclusion
The ACE blood test is a valuable tool for assessing enzyme activity related to blood pressure regulation and disease states such as sarcoidosis and cardiovascular conditions. Advances in assay technology, including phenotyping and biosensor methods, are enhancing the precision and clinical utility of ACE measurement. Genetic factors play a major role in ACE variability, and personalized approaches are increasingly important for accurate interpretation and targeted therapy.
Sources and full results
Most relevant research papers on this topic